Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Broadens Scope Of Counterfeit Drugs For Criminal Prosecution, But Definition Still Murky

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - China recently broadened its criminal definition of counterfeit drugs to include all counterfeits, not just those that cause damage to human health. The revised Criminal Law opens more manufacturers of counterfeit drugs to criminal prosecution and makes prison terms mandatory for guilty parties

You may also be interested in...



Pfizer Global Security Regional Director Harry Waskiewicz On Busting Counterfeit Drugs: An Interview With PharmAsia News (Part 2 of 2)

Pfizer case studies show counterfeiting now goes far beyond a Viagra problem.

A Long Way Still For Corrupt Business Practices In China, India - Pharmaceutical Regulatory And Compliance Congress

SINGAPORE - Major Chinese pharma companies are eyeing acquisitions of companies in lucrative Western markets to establish a global foothold, according to industry observers

A Long Way Still For Corrupt Business Practices In China, India - Pharmaceutical Regulatory And Compliance Congress

SINGAPORE - Major Chinese pharma companies are eyeing acquisitions of companies in lucrative Western markets to establish a global foothold, according to industry observers

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

SC079192

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel